Fremaux, Juliette
Venin, Claire
Mauran, Laura
Zimmer, Robert H.
Guichard, Gilles http://orcid.org/0000-0002-2584-7502
Goudreau, Sébastien R. http://orcid.org/0000-0002-2803-876X
Article History
Received: 14 November 2017
Accepted: 21 January 2019
First Online: 25 February 2019
Competing interests
: J.F., R.H.Z. and G.G. are inventors on a patent application covering GLP-1 analogues described here. J.F., C.V., L.M., R.H.Z. and S.R.G. work for UREKA Sarl, which is pursuing biomedical applications of peptide–oligourea hybrids. L.M., R.H.Z., G.G. and S.R.G. are shareholders of ImmuPharma PLC, the parent company of UREKA Sarl.